Rottenstein Law Group Comments on $3.35 Million New Jersey Vaginal Mesh Verdict Against Johnson & Johnson
On the heels of a Feb. 25 $3.35 million transvaginal mesh verdict in New Jersey Superior Court, the Rottenstein Law Group, a transvaginal mesh law firm, assesses what the verdict means for the more than 1,800 other cases pending in the United States.
Linda Gross, 47, a nurse from South Dakota, alleged that Johnson & Johnson subsidiary Ethicon’s Gynecare Prolift was unsafe and not designed properly. The jury found that Ethicon failed to adequately warn Gross’s surgeon of the risks associated with the Prolift vaginal mesh and had improperly marketed the device, but did not find that the mesh was improperly designed, according to Reuters.*
Rochelle Rottenstein, principal of the Rottenstein Law Group, said the New Jersey trial is a good sign for mesh lawsuits in other state cases and for those in the federal multidistrict litigations (MDLs 2187, 2325, 2326, 2327 and 2387, U.S. District Court, Southern District of West Virginia (Charleston)). The Rottenstein Law Group maintains an informational website on vaginal mesh cases and has been following the trial daily via news reports and the Courtroom View Network.
Read full story at PRWeb.com: Rottenstein Law Group Comments on $3.35 Million New Jersey Vaginal Mesh Verdict Against Johnson & Johnson